Last checked at 11 Nov 2016 17:47
RNS
For release: 11 November 2016
2016 Annual Report and AGM Notice
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, gives notice that copies of its 2016 Annual Report and Notice of the 2016 Annual General Meeting have been posted to shareholders. The AGM will be held at 11.00am on Wednesday, 30 November 2016 at the the Company's premises at The Innovation Centre, 48 Grafton Street, Manchester M13 9XX.In 2015/16.
Copies of these documents may be found on the Company's website (www.genedriveplc.com)
.
- Ends -
For further details please contact:
genedrive plc
David Budd: CEO +44 (0)161 989 0245
John Rylands: Finance Director
Peel Hunt LLP
James Steel +44 (0)207 418 8900
Oliver Jackson
Consilium Strategic Communications
Chris Gardner +44 (0)203 709 5700
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com
Notes to Editors
genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need or point of care diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has been successfully assessed by the Institut Pasteur, Paris.
genedrive plc was formerly Epistem plc and continues to provide contract research services to drug development companies under the Epistem brand name.
Further details can be found at: www.genedriveplc.com and www.genedrive.com